Last edition
News about "Pregabalin"
Akums Launches DCGI-Approved Triple-Action Therapy for Diabetic Neuropathic Pain
Akums Drugs & Pharmaceuticals has introduced a DCGI-approved triple-action capsule that combines pregabalin, methylcobalamin and delayed-release duloxetine to offer comprehensive management of diabetic peripheral neuropathic pain while supporting nerve regeneration.
Pregabalin | 01/07/2026 | By News Bureau | 104
India Brings Pregabalin under Schedule H1 to Curb Misuse and Strengthen Drug Regulation
Union Health Ministry has brought Pregabalin under Schedule H1 to strengthen prescription monitoring, regulate supply chains, and prevent misuse and unauthorised access to the widely used neurological medicine.
Pregabalin | 25/05/2026 | By News Bureau | 155
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy